Page 262 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )
P. 262

246            PART 4  ■  Erythrocyte Disorders





                                                                m                 m              m     -                                                     x                                  mm               m
                                 . T                          m                              m                                                        k        .

                        m                m                    . I                ,          m                                   L                                               ’     m

                                                    m    x                                         m     -

                                    m                  m                 . F        ,     m                                   m                         m      k                                           m     -

                                      m           m                                                                                           . A       -INF   x                                        q

                                                . I   m                                     m   ,                                            m           m                        m   k                        .

                 k                 m                     m                     m                k                          L                                                       m      k                    -

                      k                          m                                                                                       ,                m        , m          m                m

                                                      .                                                                                      m   . M          m                   m      k    ’  m

                    I   m                             q                            m   ,          m   -                    m                                                       q                              m

                                              m  mm                     m            ,         -                               m              m               m                   .

                                                       . T

                                                             (              .  ). T             m                          Clinical Features

                        k                                            ,        m                                            A  q                            m                       z                           m   -

                                                     m                                           .

                    A m                                                          mm              m

                         m                                                                      m                               ,                         ,                    . I                 mm         -
                                                                                                                                . T                            m                             m           ,
                                                  m                                       . A                                                                                                                           ,

                x     m                       m                             m                                                                    m

                      m                                                        m                                                    . T                      m     m

                  m                                  m                     m     m                 ;                                                                              m       m                   ,

                         m                               m              ’     m           m    m                                              m                    ,                          m     m            -

                m                                        m                                  m        .                     m   . S         m                    m                                        .

               B               m             m                                                                                  R                                                           -    m

                 m                                    x       m              ,                                                     q                            m    m                         k              -

                         m                                                                     -                           q         m                                                          m                   -

                    m                        (A  G)            . INF-α          NF                                               ,                                               mm

                                                                        m                                                             .  P     x   m                          m                    (PNH)

                                m       . T                                                                                                       x m           %                 ,        m

               INF-α          NF                                  m         m                  -                                      m    (MDS)                  m                        k  m    (AML)

               m                                                                         .                                                     m                                                 x m             %

                    T    mm

                      m                                                         m            m                                                        m     . T                                    m
                                                                                                                             m                                  mm
                                                        . I           m             m                                      m                                . O

                     CD                                                          m                -                                          m           m                     k  m                   .

                                                II            m                            HLA-DR

                                        ,           m                                                                      Laboratory Findings

                   k                                     J                           .  N                 ,

                                                                                                                           A                  m                                m

                                 mm                               m                                                                   m                                               m








                    TABLE        13.2        Phases of Aplastic Anemia





                   Phase 1: Onset of disease                      After an initiating event (e.g., viral infection), the hematopoietic compartment is destroyed by the

                                                                  immune system.


                                                                  Small numbers of surviving stem cells support adequate hematopoiesis for some time, but even-

                                                                  tually, the circulating cell counts become very low and clinical symptoms appear.


                   Phase 2: Recovery                              Either a partial response or a complete response can occur, at least initially, without increased
                                                                  numbers of stem cells.


                                                                  In a minority of patients, the primitive cell compartment appears to repopulate over time by the

                                                                  process of self-renewal of stem cells.


                   Phase 3: Late disease                          Years after recovery, blood counts may fall as a relapse of pancytopenia occurs, or an abnormal

                                                                  clone of stem cells may emerge, leading to a new diagnosis of PNH, MDS, or AML.
   257   258   259   260   261   262   263   264   265   266   267